Uncovering the TETON Phase III Clinical Trial of Inhaled Treprostinil in the Treatment of Idiopathic Pulmonary Fibrosis

Time: 9:10 am
day: Day Two


  • Reviewing the background on inhaled treprostinil development and potential for treatment in IPF
  • Exploring key study design and attributes of the TETON phase III clinical program